Single Versus Multiple Vessels Endovascular Tibial Arteries Revascularization for Critical Limb Ischemia
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to Compare the outcomes of angioplasty for single tibial vessel occlusion versus multiple tibial vessel occlusions in patients with critical limb ischemia. Assess the effectiveness and safety of angioplasty in treating different extents of tibial vessel occlusions. Evaluate the impact of angioplasty on limb salvage rates, healing of ischemic wounds, and overall clinical improvement in patients with CLI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2025
CompletedFirst Submitted
Initial submission to the registry
January 16, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedFebruary 3, 2026
December 1, 2024
11 months
January 16, 2026
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Salvageable of limb(( patients don't need for major amputation )) sabe limb from major amputation
Salvageable of limb
2years
Study Arms (2)
Single tibial artery Endovascular Revascularization
ACTIVE COMPARATORWho undergo single tibial artery Endovascular Revascularization
Multiple tibialis vessels Endovascular Revascularization
SHAM COMPARATORWho undergo more than one tibial artery Revascularization
Interventions
One would undergo single tibial artery Endovascular Revascularization
Eligibility Criteria
You may qualify if:
- Patients with:
- Rutherford Class 5 and 6 Single or multiple occlusive infrapopliteal vessel lesions In-flow vessel (superficial femoral artery and popliteal artery) free from flow-limiting lesion or in-flow lesion correction with bypass or endovascular intervention during index procedure.
You may not qualify if:
- Patients with:
- Prior vascular intervention in target limb Technical/hemodynamic failure inflow occlusive disease. Patient with allergy to the contrast
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aswan Universitylead
Study Sites (1)
Aswan university hospitals
Aswān, Aswan Governorate, 81511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ali Mahmoud Galal, MD of vascular surgery
Aswan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vascular surgery resident
Study Record Dates
First Submitted
January 16, 2026
First Posted
February 3, 2026
Study Start
January 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 9, 2025
Last Updated
February 3, 2026
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE